학술논문
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)
Document Type
Artikel
Author
Source
The British journal of dermatology. 183(2):265-275
Subject
Language
English
English
English
ISSN
1365-2133